HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federico Ricci Selected Research

Macular Degeneration (Age-Related Maculopathy)

1/2022Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration.
1/2021Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study.
1/2021Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.
11/2020Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches.
1/2020An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification.
1/2020Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study.
11/2019TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing.
3/2019The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A.
2/2018Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
1/2018Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Federico Ricci Research Topics

Disease

15Macular Degeneration (Age-Related Maculopathy)
01/2022 - 01/2010
9Choroidal Neovascularization
01/2022 - 01/2010
4Inflammation (Inflammations)
05/2021 - 01/2013
3Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
05/2022 - 01/2017
3Vision Disorders (Hemeralopia)
04/2019 - 09/2007
3Macular Edema
01/2019 - 01/2015
2Ganglion Cysts (Ganglion)
05/2022 - 01/2017
2Blindness (Hysterical Blindness)
02/2022 - 07/2020
2Vascular Diseases (Vascular Disease)
05/2021 - 02/2018
2Diabetic Retinopathy (Retinopathy, Diabetic)
11/2019 - 02/2018
2Retinal Diseases
02/2018 - 01/2007
2Endophthalmitis (Ophthalmia)
01/2016 - 11/2008
2Angioid Streaks
06/2010 - 06/2010
1Hyperpigmentation
03/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Cysts
01/2020
1Pathologic Neovascularization
02/2018
1Retinal Vein Occlusion
02/2018
1Arteritis
01/2017
1Atrophy
10/2014
1Scotoma (Scintillating Scotoma)
04/2014
1Acute zonal occult outer retinopathy
04/2014
1Multifocal Choroiditis
04/2014
1Neurosyphilis (General Paresis of the Insane)
02/2014
1Chorioretinitis
02/2014
1Syphilis
02/2014
1Polypoidal Choroidal Vasculopathy
07/2012
1Hemorrhage
07/2012
1Glaucoma
01/2012
1Herpes Simplex
04/2010
1Keratitis
04/2010
1Infections
04/2010
1Colonic Neoplasms (Colon Cancer)
11/2009
1Neoplasms (Cancer)
11/2009
1Wounds and Injuries (Trauma)
11/2008
1Corneal Ulcer
11/2008
1Ulcer
11/2008
1Corneal Diseases (Corneal Disease)
01/2006
1Cataract (Cataracts)
12/2004

Drug/Important Bio-Agent (IBA)

12Retinaldehyde (Retinal)IBA
05/2022 - 11/2008
8Ranibizumab (Lucentis)FDA Link
01/2022 - 06/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021 - 07/2012
4Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2009
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2017 - 04/2014
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2014 - 06/2010
2afliberceptIBA
11/2019 - 11/2017
2SteroidsIBA
01/2019 - 01/2016
1Monophenol Monooxygenase (Tyrosinase)IBA
03/2022
1Biosimilar PharmaceuticalsIBA
01/2022
1AngiopoietinsIBA
05/2021
1Vascular Endothelial Growth FactorsIBA
01/2021
1N-acetyltryptophanamide (NATA)IBA
11/2019
1MicroRNAs (MicroRNA)IBA
03/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2019
1Prostaglandins FIBA
02/2018
1Oxygen (Dioxygen)IBA
02/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2018
1Fluorescein (Funduscein)FDA LinkGeneric
01/2017
1Platelet-Derived Growth FactorIBA
01/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Bevacizumab (Avastin)FDA Link
01/2016
1Adalimumab (Humira)FDA Link
04/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2014
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
02/2014
1Interleukin-8 (Interleukin 8)IBA
01/2013
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
06/2010
1Verteporfin (Visudyne)FDA Link
06/2010
1Triamcinolone (Aristocort)FDA Link
06/2010
1Pharmaceutical PreparationsIBA
01/2010
1pegaptanib (Macugen)FDA Link
01/2010
1Protein Isoforms (Isoforms)IBA
11/2009
1ClusterinIBA
11/2009
1GATIBA
01/2006
1Phosmet (Prolate)IBA
12/2004

Therapy/Procedure

9Therapeutics
05/2021 - 01/2007
3Intravitreal Injections
01/2016 - 07/2012
3Photochemotherapy (Photodynamic Therapy)
10/2014 - 06/2010
2Retreatment
11/2019 - 04/2019
2Telescopes
01/2012 - 09/2007
1Lasers (Laser)
02/2018
1Precision Medicine
01/2018
1Aftercare (After-Treatment)
02/2014
1Penetrating Keratoplasty
04/2010
1Injections
01/2010
1Vitrectomy
11/2008